Assessment of Human Interleukin-24 Expression in Thalassemic Patients and Investigation of Current Prescription Pattern in Thalassemia
Abstract
Abstract Views: 400
Interleukin (IL)-24 or melanoma differentiation-associated gene-7 (MDA7) belongs to the family of cytokines initially obtained from malignant tissues and manifests itself in various types of cells (of a large size). Thus, they play a crucial part in anemias. The current study aims to analyze the activation and involvement of IL-4 in thalassemia patients. For this purpose, a study population of 50 patients was randomly selected to study the prescription pattern and blood samples for the activation of IL-24 by utilizing the RT-PCR procedure. Extraction of mRNA was followed by cDNA synthesis, further followed by real-time polymerase chain reaction (RT-PCR). Based on RNA extraction, 31 samples were selected to study the expression of MDA-7 gene in blood samples. Patients were randomly divided into two groups based on the number of transfusions at the time of blood sampling. Group 1 comprised patients with more than 100 transfusions, while Group 2 comprised patients with less than 100 transfusions. Prescription patterns showed the recommendation of approximately the same classes of drugs which are particularly used for thalassemic patients. The findings from gel electrophoresis were analyzed visually. These showed the IL-24 expression in the majority of patients included in Group 1, while no expression was found in individuals included in Group 2. The results revealed the relationship of IL-24 with thalassemia owing to its expression; however, the exact mechanism and contributing factors still remain unknown. Hence, further investigation is needed to rule out the involvement of IL-24 in thalassemia.
Downloads
References
Mohammad AM, Dawad MM, Kashmoola MA, Al-Allawi N. Doppler-defined pulmonary hypertension in β-thalassemia major in Kurdistan, Iraq. PLoS One. 2020;15(12):e0243648. https://doi.org/10.1371/journal.pone.0243648
Angastiniotis M, Eleftheriou A, Galanello R, et al. Prevention of Thalassaemias and Other Haemoglobin Disorders. 3rd ed. Nicosia, Cyprus: Thalassaemia International Federation; 2013.
Tartaglione I, Carfora R, Brotto D, et al. Hearing loss in beta-thalassemia: Systematic review. J Clin Med. 2022;11(1):e102. https://doi.org/10.3390/jcm11010102
Origa R. β-Thalassemia. Genet Med. 2017;19(6):609–619. https://doi.org/10.1038/gim.2016.173
Kitiashvili M. Beta thalassemia: Pathogenesis, progression, and treatment [Master’s thesis]. New York: Boston University; 2022. https://hdl.handle.net/2144/45740
Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the management of transfusion dependent thalassemia. Nicosia, Cyprus: Thalassemia International Federation; 2014. https://europepmc.org/article/med/24672826
Ganzella M, Zago MM. The experience of thalassemic adults with their treatment. Rev Latino-Am Enfermagem. 2011;19(4). https://doi.org/10.1590/S0104-11692011000400016
Pichamuthu BG, Arunachalam KD, Kalpana B. Current and future therapies in thalassemia: Beginning of a new era. Ann Romanian Soc Cell Biol. 2021;25(6):9672–9678.
Altaf SY, Apperley JF, Olavarria E. Matched unrelated donor transplants – state of the art in the 21st century. Semin Hematol. 2016;53(4):21–29. https://doi.org/10.1053/j.seminhematol.2016.07.002
Zhang JM, An J. Cyrokines, inflammation and pain. Int Anesthesiol Clin. 2007;45(2):27–37. https://doi.org/10.1097%2FAIA.0b013e318034194e
Liu Z, Guo C, Das SK, et al. Engineering T cells to express tumoricidal MDA-7/IL24 enhances cancer immunotherapy. Cancer Res. 2021;81(9):2429–2441. https://doi.org/10.1158/0008-5472.CAN-20-2604
Haghpanah S, Hosseini-Bensenjan M, Sayadi M, et al. Cytokine levels in patients with β-Thalassemia major and healthy individuals: A systematic review and meta-analysis. Clin Lab. 2022;69. https://doi.org/10.7754/Clin.Lab.2022.220142
Ozturk O, Yaylim I, Aydin M, et al. Increased plasma levels of interleukin-6 and interleukin-8 in β-thalassaemia major. Haematologia. 2001;31(3):237–244. https://doi.org/10.1163/15685590152763782
Agarwal S, Piesco NP, Johns LP, Ricelli AE. Differential expression of IL1 beta, TNF alpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res. 1995;74(4):1057–1065. https://doi.org/10.1177/00220345950740040501
Uguccioni M, Meliconi R, Nesci S, et al. Elevated interleukin-8 serum concentrations in, β-thalassemia and graft-versus host disease. Blood. 1993;81(9):2252–2256. https://doi.org/10.1182/blood.V81.9.2252.2252
Rougier F, Cornu E, Praloran V, Denizot Y. IL-6 and IL-8 production by human bone marrow stromal cells. Cytokine. 1998;10(2):93–97. https://doi.org/10.1006/cyto.1997.0262
Copyright (c) 2023 Babar Saeed, Mariam Busharat, Fardah Farooq, Muhammad Ikram, Zia Uddin, Nabi Shah, Muhammad Imran Amirzada
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal
